[1] |
ZHAO Lu, LI Fuyong, WEN Binhong, LI Daowei.
Effects of stains on hyperlipidemia and pain relieve of patients with chronic migraine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 671-675.
|
[2] |
HU Kangyi, CAO Linzhong, WAN Chaochao, SHANG Zhengya, YANG Xiaorui, ZHANG Yongjie.
Research progress of traditional Chinese medicine regulating mitochondrial function in the treatment of steroid-induced femoral head necrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 688-696.
|
[3] |
QIN Wenxiu, XU Junfeng, YANG Ting, WANG Pingfei.
Research progress on signaling pathway of tanshinoneIIA in treatment of nerve injury after ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 705-713.
|
[4] |
LI Yanyang, WANG Yunjiao, LV Shichao.
Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
|
[5] |
LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao.
Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593.
|
[6] |
QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi.
Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue"
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 429-437.
|
[7] |
TANG Zizhao, NIE Fangqin, YAN Xin, FU Yangxia, HUANG Jun, WANG Xia, GUO Ren.
Effect of Atglistatin on PA-induced VSMCs proliferation and ATGL expression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 29-35.
|
[8] |
CHEN Shengfu, LI Xiaolin, WANG Weigang, DU Weize, LI Maoxing.
Research progress on antipyretic effect of Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 334-344.
|
[9] |
WANG Wenjuan, QI Mingrui, TIAN Limin.
Research progress on Nrf2 in diabetic cardiomyopathy and intervention of traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1163-1170.
|
[10] |
XU Ke, GAO Junwei, LIU Peng, SHEN Zhengri, JIA Hui, WU Chenguang, TIAN Feng, WANG Lifan, LI Ping.
Tangshen formula improves cholesterol uptake and efflux of macrophages induced by high lipid via activating PGC-1α/LXR/ABCA1 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 978-985.
|
[11] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
[12] |
YIN Yujie, CHANG Liping.
Pharmacological research and clinical applications progress of Lianhua Qingwen capsules/granules in respiratory diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1174-1180.
|
[13] |
MU Xin, ZHAO Ying, ZHANG Lan, CUI Yimin, ZHANG Yongxiang, DU Guanhua.
Drug clinical trial of COVID-19 in China: A brief analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 869-877.
|
[14] |
ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping.
Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
|
[15] |
FENG Rui, ZHANG Jiali, HE Mingchao, LI Yue, ZHANG Yan.
Pharmacological targets and clinical application of traditional Chinese medicine and active components in the prevention and treatment for depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 467-474.
|